RANIERI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 5089
NA - Nord America 4578
AS - Asia 1691
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 7
OC - Oceania 4
Totale 11381
Nazione #
US - Stati Uniti d'America 4559
IE - Irlanda 1918
CN - Cina 1237
UA - Ucraina 1091
SE - Svezia 844
IT - Italia 483
FR - Francia 257
TR - Turchia 233
FI - Finlandia 201
IN - India 200
DE - Germania 100
GB - Regno Unito 97
BE - Belgio 47
RU - Federazione Russa 21
CA - Canada 19
NL - Olanda 15
EU - Europa 9
CL - Cile 7
IR - Iran 6
RO - Romania 5
ES - Italia 4
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HK - Hong Kong 3
JP - Giappone 3
AU - Australia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SG - Singapore 2
AT - Austria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
LU - Lussemburgo 1
MN - Mongolia 1
PH - Filippine 1
TH - Thailandia 1
Totale 11381
Città #
Dublin 1918
Chandler 999
Jacksonville 772
Nyköping 548
Dearborn 541
Nanjing 378
Wilmington 239
Princeton 179
San Mateo 157
Nanchang 145
Beijing 134
Ann Arbor 122
Foggia 95
Shenyang 84
Woodbridge 83
Boardman 81
Des Moines 71
Hebei 68
Tianjin 68
Helsinki 62
Kunming 51
Brussels 45
Changsha 41
Hangzhou 31
Jiaxing 31
Jinan 30
Falls Church 29
Hilden 25
Bari 24
Zhengzhou 24
Ningbo 22
Rome 20
Augusta 19
Noci 17
Norwalk 17
Changchun 16
Lanzhou 16
Stevenage 15
Philadelphia 14
Taizhou 14
Toronto 14
Auburn Hills 13
Fuzhou 13
Houston 12
Guangzhou 11
Saint Petersburg 10
Leawood 9
Milan 9
Orange 9
Rotterdam 9
San Francisco 9
Shanghai 9
Latina 8
Molfetta 8
New York 8
Redwood City 8
Acquaviva Delle Fonti 7
Florence 7
Fairfield 6
Hefei 6
Kocaeli 6
London 6
Los Angeles 6
Ashburn 5
Rockville 5
Bisceglie 4
Borås 4
Fremont 4
Haikou 4
Mountain View 4
Palese 4
Pesaro 4
Redmond 4
Torremaggiore 4
Washington 4
Ardabil 3
Avigliano 3
Bitonto 3
Bologna 3
Chicago 3
Jerusalem 3
Paris 3
Shaoxing 3
Taiyuan 3
Trani 3
Altamura 2
Ariccia 2
Bangalore 2
Bergamo 2
Catania 2
Cittiglio 2
Dallas 2
Favaro Veneto 2
Gothenburg 2
Illasi 2
Lizzanello 2
Manfredonia 2
Meta 2
Montelupone 2
Naples 2
Totale 7558
Nome #
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 193
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 128
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 127
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 125
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 120
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 115
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 107
cell carcinoma cell line and use thereof. 105
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 103
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 102
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 102
IgA nephropathy: pros and cons for a familial disease. 101
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 101
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 101
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 97
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 92
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 92
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 91
Renal Carcinoma Cell Line and Use Thereof 88
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 88
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 88
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 86
Renal cortical complement C3 gene expression in IgA nephropathy 86
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 85
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 85
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 85
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 84
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 84
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 83
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 83
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 82
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 81
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 81
Urinary epidermal growth factor concentration in patients affected by ADPKD. 81
Reclassification of glomerulopathies: which role for the podocyte? 80
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 80
Immunologic Response to RCC. 79
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 79
Growth factors and their receptors in the progression of renal damage. 79
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 79
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 79
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 79
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 79
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 78
Linea cellulare di carcinoma renale e suo uso 78
Biosimilar: can we manage biopharmaceutical heterogeneity? 77
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 77
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 77
Renal and upper urinary tract tumors: what the nephrologist should know 76
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 76
Is Berger's disease a hereditary nephritis? 75
Cytotoxic T-Cells Methods and Protocols Preface 74
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 74
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 73
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 73
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 73
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 73
TLR7 and TLR8 as targets for tumor immunotherapy 73
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 72
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 72
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 72
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 70
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 70
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 69
Salivary proteomic signatures of oral squamous cell carcinoma. 69
Platelet-derived growth factor and proliferative glomerulonephritis. 68
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 68
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 68
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 67
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 67
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 67
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 67
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 67
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 67
Diagnostic and prognostic markers of renal cell carcinoma 67
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 67
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 66
TGF-β promotes immune suppression by inhibiting Treg cell apoptosis 66
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 66
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 66
Diabetes Mellitus (DM) reduces survival in patients with renal cell carcinoma (RCC) : role of OGG1 and tuberine 66
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 65
Current insights in renal cell cancer pathology 65
Interferon-alpha (IFN-alpha) –conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients 65
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 65
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. 65
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 65
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 65
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 64
Thrombin modulate T cells response induced by dendritic cells (DC) in kidney transplant recipients with delayed graft function (DGF) 64
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 63
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 63
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 63
Monitoring biological action of rapamycin in renal transplantation. 63
Expression of transforming growth factor-beta 1 in thyroid tumor 62
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 62
Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy 62
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 62
CTL ELISPOT AssayCytotoxic T-Cells 62
Dendritic cells transduced with an adenovirus vector enconding Epstein-Barr virus latent mebrane protein 2B: a new modality for vaccination 61
Totale 7962
Categoria #
all - tutte 34135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201811 0000 00 00 00011
2018/20191096 5313211 230208 24822 174672174
2019/20202537 50231310638 308329 39776 2073320622
2020/20211547 179516758 180114 22243 295263174
2021/20221139 157141633 11946 4179 18713939269
2022/20234452 372177237274 257365 54323 223861940
Totale 11828